ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects

Newron Pharmaceuticals SPA · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
parkinson-s-disease
parkinson's disease, safinamide - parkinson's disease - levodopa induced dyskinesia, advanced idiopathic pd patients treated with l-dopa and suffering from temporally predictable l-dopa induced peak-dose dyskinesia., interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 874759
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.